Kingdon Capital Management, L.L.C. - Significant Ownership

Signature - Title
/s/ Richard Weinstein - Richard Weinstein/Chief Operating Officer & General Counsel
Location
New York, NY
Summary
This page shows a list of all the recent SCHEDULE 13D/G filings made by Kingdon Capital Management, L.L.C..

Significant Ownership of Kingdon Capital Management, L.L.C.

Sym Company Class Ownership Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
NVNO enVVeno Medical Corporation Common Stock, $0.00001 par value 7.1% $1.18M 1.36M Kingdon Capital Management, L.L.C. Sep 2, 2025
OPTN OptiNose, Inc. Common Stock, $0.001 par value per share 5.1% $4.68M 520K KINGDON CAPITAL MANAGEMENT, L.L.C. Apr 9, 2025
JSPR Jasper Therapeutics, Inc. Voting Common Stock, par value $0.0001 per share 5.1% $3.46M 765K KINGDON CAPITAL MANAGEMENT, L.L.C. Jul 3, 2025

Schedules 13D/G Reported by Kingdon Capital Management, L.L.C.:

Sym Target Class Ownership Change Current Shares Change Value Reporting name Form Report Period Date Filed
* An asterisk sign (*) next to the price indicates that the price is likely invalid.